Precision Medicine/Personalized Medicine

Most medical treatments have been designed for the average patient, meaning the same medicine, dosage, and duration are given based on the type of disease. As a result, treatments can be very successful for some people but not for others.

Precision or personalized medicine changes the one-size-fits-all approach. It takes into account individual differences in people’s genes, environments, and lifestyles. Precision medicine gives researchers and health care providers tools to better understand the complex mechanisms underlying a patient’s health, disease, or condition, and to better predict which treatments will be most effective.

Advances in precision medicine have already led to new discoveries and treatments tailored to specific characteristics of individuals, such as a person’s genetic makeup or the genetic profile of a person’s tumor. This is leading to a transformation in the way we can treat diseases such as cancer.

On January 30, 2015, U.S. President Barack Obama spoke about the Precision Medicine Initiative in the East Room of the White House. Huntsman Cancer Institute’s CEO and Director Mary Beckerle, PhD, was honored to attend. Read a transcript of the President’s remarks that day and view a PDF of the Precision Medicine Infographic from the National Institutes of Health.

Dr. Beckerle at the White House

After the Precision Medicine conference, Dr. Beckerle wrote an op-ed published in the Salt Lake Tribune: Obama’s ‘precision medicine initiative’ is a moon worth shooting for

Learn about the latest in precision medicine happening at Huntsman Cancer Institute (HCI):